Cite Filings / KROS
Feed Companies Filings Check
Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Filings Financials Insiders Search text
All 541 Financials 184 Shareholder Meetings 6 Executive Compensation 169 Insider Trading 207 Beneficial Ownership Interest 66 Business Combinations 160 Public Offerings 20 Mutual Funds and ETFs 6 Others 61
›
Filed in
  1. No filings match these filters. Clear filters
  2. 3 Insider Initial Statement of Ownership 2020-04-07
  3. 3 Insider Initial Statement of Ownership 2020-04-07
  4. 3 Insider Initial Statement of Ownership 2020-04-07
  5. 3 Insider Initial Statement of Ownership 2020-04-07
  6. 3 Insider Initial Statement of Ownership 2020-04-07
  7. 3 Insider Initial Statement of Ownership 2020-04-07
  8. 3 Insider Initial Statement of Ownership 2020-04-07

Page 11 of 11 · 207 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…